Validation of postoperative residual contrast-enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma

BACKGROUND: In the current study, we pooled imaging data in newly diagnosed glioblastoma (GBM) patients from international multicenter clinical trials, single institution databases, and multicenter clinical trial consortiums to identify the relationship between postoperative residual enhancing tumor...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Ellingson, Benjamin M, Abrey, Lauren E, Nelson, Sarah J, Kaufmann, Timothy J, Garcia, Josep, Chinot, Olivier, Saran, Frank, Nishikawa, Ryo, Henriksson, Roger, Mason, Warren P, Wick, Wolfgang, Butowski, Nicholas, Ligon, Keith L, Gerstner, Elizabeth R, Colman, Howard, de Groot, John, Chang, Susan, Mellinghoff, Ingo, Young, Robert J, Alexander, Brian M, Colen, Rivka, Taylor, Jennie W, Arrillaga-Romany, Isabel, Mehta, Arnav, Huang, Raymond Y, Pope, Whitney B, Reardon, David, Batchelor, Tracy, Prados, Michael, Galanis, Evanthia, Wen, Patrick Y, Cloughesy, Timothy F
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2018
Matèries:
Neuroimaging
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6071654/
https://ncbi.nlm.nih.gov/pubmed/29660006
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy053
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars